ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,524Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 35

$695K Total Retail Price of All Prescriptions

Rank: 14 out of 35

422 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 422 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

6% of this provider’s 422 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

0% of this provider’s 11,333 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 33.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
DONEPEZIL HCL 620 607 1 7
FUROSEMIDE 545 539 2 1
LEVOTHYROXINE SODIUM 542 542 3 3
POLYETHYLENE GLYCOL 3350 398 382 4 15
WARFARIN SODIUM 392 392 5 8
SERTRALINE HCL 349 349 6 18
LISINOPRIL 348 348 7 5
NAMENDA 343 343 8 12
SIMVASTATIN 318 313 9 6
OMEPRAZOLE 308 303 10 4
ALENDRONATE SODIUM 293 293 11 33
AMLODIPINE BESYLATE 261 261 12 9
METOPROLOL TARTRATE 253 253 13 11
METOPROLOL SUCCINATE 192 191 14 20
POTASSIUM CHLORIDE 192 179 14 10
CYMBALTA 170 170 16 17
VENLAFAXINE HCL ER 139 138 17 89
TRAMADOL HCL 136 135 18 24
TAMSULOSIN HCL 130 128 19 29
MIRTAZAPINE 127 127 20 16
GABAPENTIN 124 111 21 14
GALANTAMINE HBR 118 118 22 189
HYDROCODONE-ACETAMINOPHEN 116 116 S3 23 2
EXELON 114 114 24 59
CITALOPRAM HBR 112 112 25 13
ATENOLOL 111 111 26 31
TRAZODONE HCL 111 98 26 23
PANTOPRAZOLE SODIUM 103 103 28 37
PREDNISONE 95 95 29 36
LOSARTAN POTASSIUM 95 95 29 38
CARVEDILOL 94 94 31 25
ALLOPURINOL 91 91 32 47
QUETIAPINE FUMARATE 88 88 33 39
DILTIAZEM 24HR ER 85 85 34 139
DIGOXIN 80 80 35 49
DIVALPROEX SODIUM 77 77 36 21
PRAVASTATIN SODIUM 74 71 37 32
OLANZAPINE 74 74 37 40
CLOPIDOGREL 69 69 39 34
IPRATROPIUM-ALBUTEROL 69 69 39 64
CEPHALEXIN 69 65 39 50
ADVAIR DISKUS 65 65 42 46
FAMOTIDINE 65 65 42 35
HYDROCHLOROTHIAZIDE 60 60 44 22
ISOSORBIDE MONONITRATE ER 60 60 44 43
FLUOXETINE HCL 55 43 46 63
NEXIUM 54 54 47 50
HYDRALAZINE HCL 52 52 48 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.